Search Results for: potti

Bone researcher with lifetime funding ban earns third retraction

A researcher who received a lifetime funding ban for misconduct from a Canadian agency has logged her third retraction, after a re-analysis of her work unveiled “serious inconsistencies.” In July, the Canadian Institutes of Health Research (CIHR) released a report about Sophie Jamal, following an investigation by her former employer, The Women’s College Hospital in Toronto, Canada. … Continue reading Bone researcher with lifetime funding ban earns third retraction

We’ve temporarily removed a Retraction Watch post. Here’s why. (Hint: A bad law.)

Longtime Retraction Watch readers may recall that in 2013, we were forced to temporarily remove ten posts following a false — and frankly ridiculous — copyright infringement claim. Well, it’s happened again. On Wednesday, our host, Bluehost, forwarded us another false copyright claim — aka a Digital Millennium Copyright Act (DMCA) takedown notice — by someone … Continue reading We’ve temporarily removed a Retraction Watch post. Here’s why. (Hint: A bad law.)

Weekend reads: Fake scientists; fake research; major evils of modern research

The week at Retraction Watch featured the story of a graduate student who fought back after being caught in the middle of a fraud case, and the retraction of a hotly debated paper from Nature Cell Biology. Here’s what was happening elsewhere:

Error in one line of code sinks cancer study

Authors of a 2016 cancer paper have retracted it after finding an error in one line of code in the program used to calculate some of the results. Sarah Darby, last author of the now-retracted paper from the University of Oxford, UK, told Retraction Watch that the mistake was made by a doctoral student. When … Continue reading Error in one line of code sinks cancer study

Amid controversial Sarepta approval decision, FDA head calls for key study retraction

The head of the U.S. Food and Drug Administration (FDA) has called for the retraction of a study about a drug that the agency itself approved earlier this week, despite senior staff opposing the approval. On September 19, the FDA okayed eteplirsen to treat Duchenne muscular dystrophy (DMD), a rare genetic disorder that results in muscle degeneration and … Continue reading Amid controversial Sarepta approval decision, FDA head calls for key study retraction

“We should err on the side of protecting people’s reputation:” Management journal changes policy to avoid fraud

How can academic journals ensure the integrity of the data they publish? For one journal, the key is looking deeply at statistics, which revealed crucial problems in the research of recent high-profile fraudsters such as Anil Potti. Editor-in-chief of the Journal of Management, Patrick Wright from the University of South Carolina, recently authored an editorial about how he’s … Continue reading “We should err on the side of protecting people’s reputation:” Management journal changes policy to avoid fraud

Leiden requests two retractions over misconduct

The Leiden University Medical Center (LUMC) has asked a journal to retract two papers after revealing a former employee manipulated data. The report does not name the individual nor the journal, but notes that they work in a molecular field, and are currently employed by a university outside The Netherlands. According to a news release about … Continue reading Leiden requests two retractions over misconduct

Publicly available data on thousands of OKCupid users pulled over copyright claim

The Open Science Framework (OSF) has pulled a dataset from 70,000 users of the online dating site OkCupid over copyright concerns, according to the study author. The release of the dataset generated concerns, by making personal information — including personality traits — publicly available. Emil Kirkegaard, a master’s student at Aarhus University in Denmark, told us that … Continue reading Publicly available data on thousands of OKCupid users pulled over copyright claim

Weekend reads: Disney retraction request; NEJM under fire; how to fight unfavorable reviews

The week at Retraction Watch featured the retraction of a hoax article from a philosophy journal and an image in a paper that looked familiar because it was from a catalog. Here’s what was happening elsewhere:

Author with seven retractions makes Thomson Reuters list of top scientists — plus another twist

A cancer researcher who recently retired from MD Anderson Cancer Center —  and also recently lost seven papers from one journal following a multi-year investigation — is one of the world’s top scientists, according to a new ranking. In Thomson Reuters Web of Science’s 2015 list of The World’s Most Influential Scientific Minds, Bharat Aggarwal’s name tops the section … Continue reading Author with seven retractions makes Thomson Reuters list of top scientists — plus another twist